NIFTY MIDSML HLTH Index PE Ratio
The NIFTY MIDSML HLTH P/E ratio is 59.94 on a market cap weighted basis, derived from the price-to-earnings data of 29 of 30 index constituents with valid EPS. Of these, 1 stocks trade at a low P/E ratio below 15, 2 at moderate valuations between 15 and 25, 10 at elevated earnings multiples between 25 and 50, and 16 at very high valuations above 50. For live index level, EPS data and the full index overview, see NIFTY MIDSML HLTH index composition. Use the NIFTY MIDSML HLTH PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 30 constituents.
NIFTY MIDSML HLTH PE Ratio Distribution — Low, Moderate, High & Very High
1 low (<15), 2 moderate (15–25), 10 high (25–50), 16 very high (50+) among 30 NIFTY MIDSML HLTH stocks. Analyse NIFTY MIDSML HLTH constituent earnings to understand aggregate earnings trends across constituents.
NIFTY MIDSML HLTH PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY MIDSML HLTH over 6 years — 29 stocks with valid EPS, current P/E 59.94.
NIFTY MIDSML HLTH Component Stocks — P/E Ratio & EPS
29 of 30 NIFTY MIDSML HLTH constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
LUPIN
Lupin
|
Healthcare | ₹1.1 Lakh Cr | ₹128.45 | 21.3 |
|
MAXHEALTH
Max Healthcare Institute
|
Healthcare … | ₹1.1 Lakh Cr | ₹14.83 | 76.4 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹1.0 Lakh Cr | ₹46.35 | 54.1 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹93.3K Cr | ₹60.34 | 26.9 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹79.8K Cr | ₹16.47 | 92.8 |
|
FORTIS
Fortis Healthcare
|
Healthcare … | ₹74.0K Cr | ₹13.80 | 69.1 |
|
BIOCON
Biocon
|
Healthcare | ₹68.8K Cr | ₹2.82 | 188.6 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹67.8K Cr | ₹192.51 | 28.5 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹64.1K Cr | ₹48.26 | 45.8 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹55.8K Cr | ₹730.36 | 36.6 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹45.1K Cr | ₹46.94 | 38.2 |
|
AJANTPHARM
Ajanta Pharma
|
Healthcare | ₹42.1K Cr | ₹84.53 | 39.4 |
|
GLAND
Gland Pharma
|
Healthcare | ₹42.1K Cr | ₹62.35 | 39.5 |
|
NH
Narayana Hrudayalaya
|
Healthcare … | ₹41.0K Cr | ₹39.67 | 50.7 |
|
ASTERDM
Aster DM Healthcare
|
Healthcare … | ₹40.9K Cr | ₹7.53 | 95.9 |
|
GLAXO
GlaxoSmithKline Pharmaceuticals
|
Healthcare | ₹40.8K Cr | ₹61.15 | 39.3 |
|
JBCHEPHARM
J B Chemicals and Pharmaceuticals
|
Healthcare | ₹39.5K Cr | ₹45.16 | 55.1 |
|
MEDANTA
Global Health
|
Healthcare … | ₹35.6K Cr | ₹20.71 | 65.5 |
|
KIMS
Krishna Institute of Medical Scien…
|
Healthcare … | ₹33.8K Cr | ₹6.03 | 143.0 |
|
LALPATHLAB
Dr. Lal Path Labs
|
Healthcare … | ₹28.2K Cr | ₹30.24 | 55.5 |
|
NEULANDLAB
Neuland Laboratories
|
Healthcare | ₹24.3K Cr | ₹283.71 | 66.7 |
|
PPLPHARMA
Piramal Pharma
|
Healthcare | ₹23.3K Cr | - | N/A |
|
GRANULES
Granules
|
Healthcare | ₹21.2K Cr | ₹24.47 | 34.7 |
|
PFIZER
Pfizer
|
Healthcare | ₹20.7K Cr | ₹157.92 | 28.7 |
|
POLYMED
Poly Medicure
|
Healthcare | ₹17.1K Cr | ₹31.79 | 53.1 |
|
SYNGENE
Syngene International
|
Healthcare | ₹17.1K Cr | ₹7.87 | 54.8 |
|
COHANCE
Cohance Lifesciences
|
Healthcare | ₹16.9K Cr | ₹4.69 | 115.5 |
|
NATCOPHARM
Natco Pharma
|
Healthcare | ₹16.7K Cr | ₹79.20 | 11.8 |
|
APLLTD
Alembic Pharmaceuticals
|
Healthcare | ₹16.4K Cr | ₹34.33 | 24.5 |
|
RAINBOW
Rainbow Childrens Medicare
|
Healthcare … | ₹14.4K Cr | ₹27.41 | 52.0 |
Track NIFTY MIDSML HLTH PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY MIDSML HLTH Trade to Journal